Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000728889-19-000064
Filing Date
2019-01-14
Accepted
2019-01-14 15:12:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 arrowheadpharmaincsc13ga.htm SC 13G/A 26625
  Complete submission text file 0000728889-19-000064.txt   28674
Mailing Address 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

EIN.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-48710 | Film No.: 19524934
SIC: 2834 Pharmaceutical Preparations